跳至主要内容
临床试验/NCT05844059
NCT05844059招募中不适用

Lower Urinary Tract Symptoms After Intravesical Therapy With Mitomycin C or BCG in Patients With Carcinoma of the Bladder

Ludwig-Maximilians - University of Munich1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年4月21日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
1
主要终点
Effect of instillation therapy on lower urinary tract symptoms

研究概览

简要总结

With this prospective, observational study, we would like to investigate the effect of instillation therapy using BCG or mitomycin C on short- and long-term irritative and obstructive lower urinary tract symptoms using validated questionnaires. The study will objectify the lower urinary tract symptoms and thereby provide better recommendations for therapy with mitomycin C or BCG.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Urinary bladder carcinoma requiring instillation therapy
  • Complete resection of the tumor
  • No intravesical chemotherapy in the last 3 months

排除标准

  • Patients who are unable to complete the questionnaires
  • Patients who are not willing to participate
  • Patients with contraindications for instillation therapy (allergic reactions, immunosuppression)

结局指标

主要结局

Effect of instillation therapy on lower urinary tract symptoms

时间窗: During the study period approximately 12 months

Lower urinary tract symptoms will be measured with validated questionnaires such as the BPIC-SS, the ICIQ-MLUTS (men) and the ICIQ-FLUTS (women)

Effect of instillation therapy on sexuality

时间窗: During the study period approximately 12 months

Sexuality will be measured with validated questionnaires such as the IIEF-EF (men) and the FSFI (women)

Effect of instillation therapy on quality of life

时间窗: During the study period approximately 12 months

Quality of life will be measured with validated questionnaires such as the ICIQ-OABqol

次要结局

  • Complications during instillation therapy(During the study period approximately 12 months)
  • Discontinuation rate of instillation therapy(During the study period approximately 12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Benedikt Ebner

Dr. med.

Ludwig-Maximilians - University of Munich

研究点 (1)

Loading locations...

相似试验